The Research Progress of Bufalin in the Treatment of Hepatocellular Carcinoma

被引：19

作者：

Jiang, Han-yu ^{[1
]}

Zheng, Hui-min ^{[1
]}

Xia, Cheng ^{[1
]}

Li, Xiang ^{[1
]}

Wang, Gang ^{[1
]}

Zhao, Tong ^{[1
]}

Cui, Xiao-nan ^{[2
]}

Wang, Ruo-yu ^{[1
,3
]}

Liu, Ying ^{[1
,3
]}

机构：

[1] Dalian Univ, Affiliated Zhongshan Hosp, Dept Oncol, 6 Liberat St, Dalian 116001, Peoples R China

[2] Dalian Med Univ, Affiliated Hosp 1, Dept Oncol, Dalian 116011, Liaoning, Peoples R China

[3] Key Lab Biomarker High Throughput Screening & Tar, Dalian, Peoples R China

来源：

ONCOTARGETS AND THERAPY | 2022年 / 15卷

关键词：

bufalin; cancer; therapy; signaling pathways; immunotherapy effect; CANCER-CELLS; AUTOPHAGY; APOPTOSIS; PATHWAY; PROLIFERATION; HIF-1-ALPHA; SORAFENIB; MIGRATION; INVASION; KINASE;

D O I：

10.2147/OTT.S333233

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Hepatocellular carcinoma (HCC) is one of the deadliest cancers in the world with a five-year survival rate of less than 20%. Nonetheless, selecting an appropriate therapeutic agent to inhibit the development of hepatoma cells is still a challenge. Bufalin, a component of the traditional Chinese medicine Chansu, has been shown to inhibit the proliferation, invasion and metastasis of HCC through various signaling pathways. In addition, bufalin and sorafenib demonstrate a synergistic effect in cancer therapeutics. This review highlighted on several focal signaling pathways involved in the inhibitory effects of bufalin on HCC and its synergistic mechanisms with sorafenib. The immunotherapy effect of bufalin has also been discussed as a novel property.

引用

页码：291 / 298

页数：8

共 40 条

[31] Synergistic anti-hepatoma effect of bufalin combined with sorafenib via mediating the tumor vascular microenvironment by targeting mTOR/VEGF signaling [J].

Wang, Haiyong ;

Zhang, Chenyue ;

Chi, Huiying ;

Meng, Zhiqiang .

INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) :2051-2060

[32] Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway [J].

Wang, Haiyong ;

Zhang, Chenyue ;

Xu, Litao ;

Zang, Kun ;

Ning, Zhouyu ;

Jiang, Feng ;

Chi, Huiying ;

Zhu, Xiaoyan ;

Meng, Zhiqiang .

ONCOTARGET, 2016, 7 (15) :20193-20208

[33] Increased Activation of the Wnt/β-Catenin Pathway in Spontaneous Hepatocellular Carcinoma Observed in Farnesoid X Receptor Knockout Mice [J].

Wolfe, Andy ;

Thomas, Ann ;

Edwards, Genea ;

Jaseja, Reshma ;

Guo, Grace L. ;

Apte, Udayan .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01) :12-21

[34] A/G polymorphism of matrix metalloproteinase 7 gene promoter region and cancer risk: A meta-analysis [J].

Wu, Jing ;

Guan, Xuan ;

Zhang, Kui ;

Li, Ya-Ting ;

Bai, Peng ;

Wu, Jin .

BIOMEDICAL REPORTS, 2013, 1 (05) :792-796

[35] The mTORC2-Akt1 Cascade Is Crucial for c-Myc to Promote Hepatocarcinogenesis in Mice and Humans [J].

Xu, Zhong ;

Xu, Meng ;

Liu, Pin ;

Zhang, Shu ;

Shang, Runze ;

Qiao, Yu ;

Che, Li ;

Ribback, Silvia ;

Cigliano, Antonio ;

Evert, Katja ;

Pascale, Rosa M. ;

Dombrowski, Frank ;

Evert, Matthias ;

Chen, Xi ;

Calvisi, Diego F. ;

Chen, Xin .

HEPATOLOGY, 2019, 70 (05) :1600-1613

[36] Bufalin inhibits cell proliferation and migration of hepatocellular carcinoma cells via APOBEC3F induced intestinal immune network for IgA production signaling pathway [J].

Yang, Zongguo ;

Tao, Yuquan ;

Xu, Xin ;

Cai, Feng ;

Yu, Yongchun ;

Ma, Lifang .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 503 (03) :2124-2131

[37] Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms [J].

Ye, Ming-Xiang ;

Zhao, Yi-Lin ;

Li, Yan ;

Miao, Qing ;

Li, Zhi-Kui ;

Ren, Xin-Ling ;

Song, Li-Qiang ;

Yin, Hong ;

Zhang, Jian .

PHYTOMEDICINE, 2012, 19 (8-9) :779-787

[38] Bufalin Reverses Resistance to Sorafenib by Inhibiting Akt Activation in Hepatocellular Carcinoma: The Role of Endoplasmic Reticulum Stress [J].

Zhai, Bo ;

Hu, Fengli ;

Yan, Haijiang ;

Zhao, Dali ;

Jin, Xin ;

Fang, Taishi ;

Pan, Shangha ;

Sun, Xueying ;

Xu, Lishan .

PLOS ONE, 2015, 10 (09)

[39] miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3 [J].

Zhang, Yi ;

Huang, Wei ;

Ran, Yan ;

Xiong, Yan ;

Zhong, Zibiao ;

Fan, Xiaoli ;

Wang, Zhenghua ;

Ye, Qifa .

TUMOR BIOLOGY, 2015, 36 (11) :8309-8316

[40] Bufalin attenuates the stage and metastatic potential of hepatocellular carcinoma in nude mice [J].

Zhang, Zhou-Ji ;

Yang, Yun-Ke ;

Wu, Wei-Zhong .

JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12

← 1 2 3 4 →